Cardio Diagnostics Holdings Inc (CDIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access CDIO quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Cardio Diagnostics Holdings Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5.11
Cash & Short-term Investments5.00
Accounts receivable0.01
Prepaid Expense And Other Assets Current0.80
Total Current Assets5.92
Equipment/Property/Plant Net0.70
Intangible Assets0.87
Deposits Assets, Noncurrent AS0.01
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.26
Total Assets7.77
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.10
Other Liabilities, Current0.00
Taxes Payable, Current, Total0.00
Total Current Liabilities0.60
Total Long-term Debt0.00
Other liabilities, Noncurrent0.19
FinanceAgreementPayable0.27
Operating Lease Liability Current0.24
Total Liabilities0.79
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock36.22
Retained Earnings / Accumulated Deficit-29.25
Other Equity0.00
Common Stockholder's Equity6.97
Non-controlling interests & other0.00
Total Stockholder's Equity6.97
Liabilities & Stockholder's Equity7.77
4 historic quarters locked

Sign in to unlock the full Cardio Diagnostics Holdings Inc balance sheet history.

About Cardio Diagnostics Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001553350-26-000023

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.